4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell

4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8⁺ T cell

Cell Mol Immunol. 2023 Sep;20(9):1077-1080. doi: 10.1038/s41423-023-01056-3. Epub 2023 Jun 26.

Eunjung Cho^#^{1

2}, Rohit Singh^#¹, Chungyong Han^{1

3}, Seon-Hee Kim^{1

4}, Kwang H Kim², Bo-Mi Park⁵, Dong Hoon Shin^{3

6}, Seongeun Han¹, Young H Kim⁷, Byoung S Kwon^{7

8}, Ki Taek Nam⁹, Beom K Choi^{10

11}

¹ Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.
² Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Republic of Korea.
⁴ Department of Biomedical Laboratory Science, Catholic Kwandong University, Gangneung, 25601, Republic of Korea.
⁵ Biomedicine Production Branch, Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
⁶ Anticancer Resistance Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
⁷ Eutilex Co., Ltd., Geumcheon-gu, Seoul, 08594, Republic of Korea.
⁸ Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA, 70112, USA.
⁹ Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea. kitaek@yuhs.ac.
¹⁰ Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea. magetin@gmail.com.
¹¹ Innobationbio Co., Ltd., Mapo-gu, Seoul, 03929, Republic of Korea. magetin@gmail.com.

^# Contributed equally.

No abstract available